Validation of a Lab-on-Chip Assay for Measuring Sorafenib Effectiveness on HCC Cell Proliferation

Hepatocellular carcinoma (HCC) is a highly lethal cancer, and although a few drugs are available for treatment, therapeutic effectiveness is still unsatisfactory. New drugs are urgently needed for hepatocellular carcinoma (HCC) patients. In this context, reliable preclinical assays are of paramount...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccinno, Emanuele, Monteduro, Anna Grazia, Dituri, Francesco, Rizzato, Silvia, Giannelli, Gianluigi, Maruccio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658471/
https://www.ncbi.nlm.nih.gov/pubmed/34884894
http://dx.doi.org/10.3390/ijms222313090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658471/
https://www.ncbi.nlm.nih.gov/pubmed/34884894
http://dx.doi.org/10.3390/ijms222313090

Ejemplares similares